ZAP Surgical Announces Comprehensive Webinar Series Focused on Advancing Stereotactic Radiosurgery for Treating Brain Tumors
SAN CARLOS, Calif., March 24, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc. today announced a program offering web-based educational talks focused on stereotactic radiosurgery (SRS) and its related applications. With numerous recently postponed scientific meetings resulting from the COVID-19 crisis (e.g. The Radiosurgery Society, AANS, etc.), combined with the need for "social distancing", all of the program's content will be delivered via webinar and at no cost.
Stereotactic radiosurgery is a well-studied and effective treatment for many brain cancers including primary and metastatic brain tumors. Considered an alternative to surgery for select indications, SRS is a non-invasive outpatient procedure that often provides equivalent outcomes, yet no surgical incision, and little to no recovery period.
The webinar series includes an esteemed panel of experts discussing a myriad of topics relevant to the advancement of radiosurgery. Select presentations from this program include the following:
Tue, April 7, 11:00am-11:30am EDT. "Isocentric vs. Non-Isocentric SRS for Trigeminal Neuralgia", presented by Leo Romanelli MD, Neurosurgeon, CDI Milan, and Mike Schulder MD, Neurosurgeon, North Shore University Hospital.
Thu, April 16, 11:00am-11:30am EDT. "SRS for Brain Mets ? How Big is Too Big? How Many is Too Many?", presented by Scott Soltys, Radiation Oncologist, Stanford University, and Aizik Wolf MD, Neurosurgeon, Miami Neuroscience Center.
Thu, April 23, 11:00am-11:30am EDT. "SRS vs. Surgery for Vestibular Schwannoma", presented by Alex Muacevic MD, Neurosurgeon, University of Munich, and Michael McDermott MD, Neurosurgeon, Miami Neuroscience Institute.
Wed, May 6, 11:00am-11:30am EDT. "Brain Mets: Dispelling Myths and Focusing on Fact", presented by Jason Sheehan MD, Neurosurgeon, University of Virginia.
Thu, May 14, 11:00am-11:30am EDT. "Vault-Free Radiosurgery Beam Dosimetry and Plan Quality Analysis", presented by Steve Sorensen PhD, Medical Physicist, Barrow Neurological Institute.
Wed, May 20, 11:00am-11:30am EDT. "Understanding SRS Reimbursement Trends: Past, Present and Future", presented by James Hugh, SVP, American Medical Accounting and Consulting (AMAC).
Thu, June 11, 11:00am-11:30am EDT. "Radiosurgery and Intractable Pain", presented by Eduardo Lovo MD, Neurosurgeon, International Cancer Center - El Salvador.
For additional details and to register for each event, please visit SRS-webinars.com. Capacity is limited and will be confirmed on a first-come, first-served basis. Participation is subject to approval and is limited to SRS healthcare providers and affiliated clinical staff.
About ZAP Surgical Systems, Inc. ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgerytm platform. ZAP was founded in 2014 by John R. Adler, MD, professor emeritus of neurosurgery and radiation oncology at Stanford University, and founder & CEO of ZAP Surgical Systems. Dr. Adler is also the inventor of the CyberKnife® and founder of Accuray, Inc. FDA-cleared in September 2017, ZAP-X utilizes a modern linear accelerator to eliminate the historical use of Cobalt-60 and the related costs and challenges of handling live radioactive isotopes. ZAP-X also incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. Learn more at www.zapsurgical.com.
Contact: Mark Arnold Senior Vice President, Marketing ZAP Surgical Systems, Inc. Email: [email protected]
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...
First quarter
Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).
...
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024
First Quarter 2024
Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...